Interval cancers in the Dutch breast cancer screening programme

被引:64
|
作者
Fracheboud, J
de Koning, HJ
Beemsterboer, PMM
Boer, R
Verbeek, ALM
Hendriks, JHCL
van Ineveld, BM
Broeders, MJM
de Bruyn, AE
van der Maas, PJ
机构
[1] Erasmus Univ, Nat Evaluat Team Breast Canc Screening, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Nat Evaluat Team Breast Canc Screening, Dept Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands
[3] Univ Nijmegen, Dept Epidemiol, NL-6500 HB Nijmegen, Netherlands
[4] Univ Nijmegen, Dept Radiol, NL-6500 HB Nijmegen, Netherlands
关键词
breast cancer; interval cancer; proportionate incidence; population-based screening; evaluation;
D O I
10.1038/sj.bjc.6690786
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The nationwide breast cancer screening programme in The Netherlands for women aged 50-69 started in 1989. In our study we assessed the occurrence and stage distribution of interval cancers in women screened during 1990-1993. Records of 0.84 million screened women were linked to the regional cancer registries yielding a follow-up of at least 2.5 years. Age-adjusted incidence rates and relative (proportionate) incidences per tumour size including ductal carcinoma in-situ were calculated for screen-detected and interval cancers, and cancers in not (yet) screened women, comparing them with published data from the UK regions North West and East Anglia. In total 1527 interval cancers were identified: 0.95 and 0.99 per 1000 woman-years of follow-up in the 2-year interval after initial and subsequent screens respectively in the first year after initial screening interval cancers amounted to 27% (26% after subsequent screens) of underlying incidence, and in the second year to 52% (55%). Generally, interval cancers had a more favourable tumour size distribution than breast cancer in not (yet) screened women. The Dutch programme detected relatively less (favourable) invasive cancers in initial screens than the UK programme, whereas the number of interval cancers confirms UK findings. Measures should be considered to improve the detection of small invasive cancers and to reduce false-negative rates, even if this will lead to increasing referral rates. (C) 1999 Cancer Research Campaign.
引用
收藏
页码:912 / 917
页数:6
相关论文
共 50 条
  • [31] Monitoring interval cancers in an Australian mammographic screening programme
    Kavanagh, AM
    Mitchell, H
    Farrugia, H
    Giles, GG
    JOURNAL OF MEDICAL SCREENING, 1999, 6 (03) : 139 - 143
  • [32] Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis
    Toes-Zoutendijk, Esther
    de Jonge, Lucie
    van Iersel, Carola Adriana
    Spaander, Manon C. W.
    van Vuuren, Anneke J.
    van Kemenade, Folkert
    Ramakers, Christian R.
    Dekker, Evelien
    Nagetaal, Iris D.
    van Leerdam, Monique E.
    Lansdorp-Vogelaar, Iris
    GUT, 2023, 72 (07) : 1319 - 1325
  • [33] Survival rates from interval cancer in NHS breast screening programme
    Collins, S
    Woodman, CBJ
    Threlfall, A
    Prior, P
    BRITISH MEDICAL JOURNAL, 1998, 316 (7134): : 832 - 833
  • [34] Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening
    Caldarella, A.
    Puliti, D.
    Crocetti, E.
    Bianchi, S.
    Vezzosi, V.
    Apicella, P.
    Biancalani, M.
    Giannini, A.
    Urso, C.
    Zolfanelli, F.
    Paci, E.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (02) : 181 - 185
  • [35] A simple way to measure the burden of interval cancers in breast cancer screening
    Sune Bangsbøll Andersen
    Sven Törnberg
    Elsebeth Lynge
    My Von Euler-Chelpin
    Sisse Helle Njor
    BMC Cancer, 14
  • [36] INTERVAL CANCERS AND SCREENING FOR BREAST-CANCER IN BRITISH-COLUMBIA
    MOSKOWITZ, M
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (05) : 1072 - 1074
  • [37] Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening
    A. Caldarella
    D. Puliti
    E. Crocetti
    S. Bianchi
    V. Vezzosi
    P. Apicella
    M. Biancalani
    A. Giannini
    C. Urso
    F. Zolfanelli
    E. Paci
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 181 - 185
  • [38] A simple way to measure the burden of interval cancers in breast cancer screening
    Andersen, Sune Bangsboll
    Tornberg, Sven
    Lynge, Elsebeth
    Von Euler-Chelpin, My
    Njor, Sisse Helle
    BMC CANCER, 2014, 14
  • [39] Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity
    Blom, Johannes
    Tornberg, Sven
    JOURNAL OF MEDICAL SCREENING, 2017, 24 (03) : 146 - 152
  • [40] Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme
    Gill, M. D.
    Bramble, M. G.
    Rees, C. J.
    Lee, T. J. W.
    Bradburn, D. M.
    Mills, S. J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (03) : 417 - 421